1. Home
  2. DSS vs CYCC Comparison

DSS vs CYCC Comparison

Compare DSS & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • CYCC
  • Stock Information
  • Founded
  • DSS 1984
  • CYCC 1992
  • Country
  • DSS United States
  • CYCC Malaysia
  • Employees
  • DSS N/A
  • CYCC N/A
  • Industry
  • DSS Containers/Packaging
  • CYCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSS Consumer Discretionary
  • CYCC Health Care
  • Exchange
  • DSS Nasdaq
  • CYCC Nasdaq
  • Market Cap
  • DSS 7.7M
  • CYCC 7.8M
  • IPO Year
  • DSS N/A
  • CYCC N/A
  • Fundamental
  • Price
  • DSS $0.84
  • CYCC $7.99
  • Analyst Decision
  • DSS
  • CYCC
  • Analyst Count
  • DSS 0
  • CYCC 0
  • Target Price
  • DSS N/A
  • CYCC N/A
  • AVG Volume (30 Days)
  • DSS 25.4K
  • CYCC 227.4K
  • Earning Date
  • DSS 08-14-2025
  • CYCC 08-13-2025
  • Dividend Yield
  • DSS N/A
  • CYCC N/A
  • EPS Growth
  • DSS N/A
  • CYCC N/A
  • EPS
  • DSS N/A
  • CYCC N/A
  • Revenue
  • DSS $21,252,000.00
  • CYCC $10,000.00
  • Revenue This Year
  • DSS N/A
  • CYCC $137.21
  • Revenue Next Year
  • DSS N/A
  • CYCC N/A
  • P/E Ratio
  • DSS N/A
  • CYCC N/A
  • Revenue Growth
  • DSS 10.24
  • CYCC N/A
  • 52 Week Low
  • DSS $0.72
  • CYCC $3.08
  • 52 Week High
  • DSS $1.50
  • CYCC $597.60
  • Technical
  • Relative Strength Index (RSI)
  • DSS 39.36
  • CYCC 44.20
  • Support Level
  • DSS $0.83
  • CYCC $6.91
  • Resistance Level
  • DSS $0.90
  • CYCC $8.28
  • Average True Range (ATR)
  • DSS 0.05
  • CYCC 1.09
  • MACD
  • DSS -0.01
  • CYCC -0.12
  • Stochastic Oscillator
  • DSS 15.58
  • CYCC 29.43

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

Share on Social Networks: